A Phase II Multicentre Study with Elacytarabine as Second Salvage Therapy in Patients with AML.
Conference Paper
Full Text
Duke Authors
Cited Authors
- O'Brien, S; Rizzieri, DA; Vey, N; Ravandi, F; Krug, UO; Sekeres, MA; Dennis, M; Venditti, A; Jacobsen, TF; Staudacher, K; Nilsson, BI; Giles, FJ
Published Date
- November 20, 2009
Published In
Volume / Issue
- 114 / 22
Start / End Page
- 431 - 431
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 0006-4971
Conference Name
- 51st Annual Meeting of the American-Society-of-Hematology
Conference Location
- New Orleans, LA
Conference Start Date
- December 5, 2009
Conference End Date
- December 8, 2009